Advances in Treating Chronic Back Pain: Insights from Neuroscience Research

Emerging neuroscience research offers promising new treatments for chronic back pain by targeting brain signals. Learn about innovative therapies and effective prevention strategies from UCSF experts.
Chronic back pain affects approximately 25% of Americans, presenting a significant challenge for effective treatment. Dr. Prasad Shirvalkar, a neurologist and pain medicine expert at UC San Francisco, explores the complex neural mechanisms underlying persistent back pain and examines the potential for innovative therapies.
Chronic back pain is defined as pain lasting longer than three months and can stem from various causes such as degenerative disc disease, arthritis, spinal stenosis, nerve compression, and muscle irritation. In some cases, no specific cause is identified, yet the pain is very real and debilitating.
Compared to acute back pain, which lasts days or weeks and often results from muscular strain or minor injuries, chronic pain involves long-term changes in the nervous system. Over time, pain signals can become ingrained in the brain’s wiring, affecting regions responsible for mood and cognition, complicating treatment efforts.
Understanding how these maladaptive brain changes occur is crucial for developing better interventions. Researchers focus on the nerve pathways and brain circuits involved in pain perception to identify potential targets for therapy, aiming for a breakthrough that could prevent the transition from acute to chronic pain.
Current treatments for chronic back pain are varied but often rely on trial and error. Medications like anti-inflammatory drugs, muscle relaxers, or nerve-targeted therapies sometimes help, but their efficacy is inconsistent. Non-drug approaches like physical therapy, acupuncture, epidural injections, and nerve blocks are first-line treatments, with invasive options such as spinal cord stimulation reserved for difficult cases.
Recent research by Dr. Shirvalkar’s team has made promising strides. Using advanced brain recordings, they have shown that specific brain signals correlate with pain severity. In groundbreaking studies, they have developed personalized brain stimulation therapies that target these signals. These treatments involve implanting tiny electrodes in targeted brain areas and providing electrical stimulation only when pain signals are high, reducing side effects and energy consumption.
Future directions aim to adapt this technology to noninvasive brain stimulation methods, broadening accessibility and improving quality of life for patients suffering from chronic back pain. Preventative strategies emphasize regular exercise and core strengthening activities, which promote spine stability and enhance the brain’s ability to rewire and heal.
Among recommended exercises are aerobic activities like running and moderate physical activity, as well as core-focused routines such as planks, sit-ups, and yoga or Pilates. These interventions not only support physical health but also encourage neural plasticity, offering hope for more effective management of chronic back pain in the future.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Study Finds Fewer Than 500 Neurons Play Key Role in Suppressing Binge Drinking
A groundbreaking study identifies fewer than 500 neurons in the brain that are crucially involved in suppressing binge drinking behavior, offering new insights into potential treatments for alcohol dependency.
Innovative Synthetic Protein Targets and Removes Harmful Cells, Offering New Hope for Cancer and Autoimmune Disorders
Kyoto University scientists have engineered Crunch, a customizable synthetic protein that leverages the body's natural cleanup process to target and remove harmful cells, offering new prospects for cancer and autoimmune treatments.
Abnormal Fusion Protein Creates Cell Droplets That May Promote Childhood Brain Tumors
Scientists have uncovered how an abnormal fusion protein causes cell droplet formation, potentially driving childhood brain tumors like ependymoma. This discovery opens new possibilities for targeted therapies in difficult-to-treat cancers.



